Fludarabine, mitoxantrone and dexamethasone as front-line therapy in elderly patients affected by newly-diagnosed, low-grade non-Hodgkin's lymphomas with unfavorable prognostic factors: results of a phase II study.
about
Prospective clinical study of R-CMD therapy for indolent B cell lymphoma and mantle cell lymphoma from the Hokuriku Hematology Oncology Study Group.Results of a phase II study of vorinostat in combination with intravenous fludarabine, mitoxantrone, and dexamethasone in patients with relapsed or refractory mantle cell lymphoma: an interim analysis.Efficacy and safety evaluation of fludarabine-based chemotherapy regimen for patients with non-Hodgkin lymphoma: A meta-analysis.
P2860
Fludarabine, mitoxantrone and dexamethasone as front-line therapy in elderly patients affected by newly-diagnosed, low-grade non-Hodgkin's lymphomas with unfavorable prognostic factors: results of a phase II study.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Fludarabine, mitoxantrone and ...... : results of a phase II study.
@ast
Fludarabine, mitoxantrone and ...... : results of a phase II study.
@en
type
label
Fludarabine, mitoxantrone and ...... : results of a phase II study.
@ast
Fludarabine, mitoxantrone and ...... : results of a phase II study.
@en
prefLabel
Fludarabine, mitoxantrone and ...... : results of a phase II study.
@ast
Fludarabine, mitoxantrone and ...... : results of a phase II study.
@en
P2093
P2860
P1433
P1476
Fludarabine, mitoxantrone and ...... : results of a phase II study.
@en
P2093
Anna Maria Todaro
Carmelo Giannitto-Giorgio
Dario Giuffrida
Francesco Marletta
Giuseppe Novello
Giuseppina Petralia
Maria Ursino
Mario Manusia
Nunzio Restuccia
Placida Salice
P2860
P304
P356
10.1080/1042819031000139765
P577
2004-01-01T00:00:00Z